SR121566A |
カタログ番号GC31993 |
SR121566A は新規の非ペプチド糖タンパク質 IIb/IIIa (GP IIb-IIIa) アンタゴニストであり、ADP、アラキドン酸、およびコラーゲンによって誘導されるヒト血小板凝集を 46±7.5、56±6、および 42±3 nM の IC50 で阻害できます。 、 それぞれ。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 180144-61-0
Sample solution is provided at 25 µL, 10mM.
SR121566A is a novel non-peptide Glycoprotein IIb/IIIa (GP IIb-IIIa) antagonist, which can inhibit ADP-, arachidonic acid- and collagen-induced human platelet aggregation with IC50s of 46±7.5, 56±6 and 42±3 nM, respectively.
SR121566A leads to dose-dependent increases in TTO, a statistically significant increase being observed at the doses of 0.3 mg/kg (473%) and 30 mg/kg (771%), respectively[2].
[1]. Herault JP,et al. Effect of SR121566A, a potent GP IIb-IIIa antagonist on platelet-mediated thrombin generation in vitro and in vivo. Thromb Haemost. 1998 Feb;79(2):383-8. [2]. Lorrain J, et al. Effects of SanOrg123781A, a synthetic hexadecasaccharide, in a mouse model of electrically induced carotid artery injury: synergism with the antiplatelet agent clopidogrel. J Pharmacol Exp Ther. 2004 Apr;309(1):235-40.
Average Rating: 5
(Based on Reviews and 5 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *